Monday, May 6, 2024
Home Drones Page 2

Drones

    Most popular

    Montana Based Drone Maker Skyfish Banks $20 Million.

    Drones Editor / Curator -
    American drone maker Skyfish secures over $20 million in Series Seed funding; appoints Cell Tower Industry Veteran Steven Bernstein to its Board of...
    Draganfly, Drone Stock Review

    Draganfly (DPRO) Closes $20 Million Public Offering. Now NASDAQ Listed.

    Drones Editor / Curator -
    Los Angeles, CA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Draganfly Inc. (Nasdaq: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), a...
    Drone Stock Review, Cameron Chell

    Draganfly (DPRO) the Tesla of Drones, Locked and Loaded.

    Drones Editor / Curator -
    Closes $20 Million Raise.Uplists to NASDAQ.Pilot Training for First Responders Firefighters, Search and Rescue Commences.Reports Record Revenues for Second Quarter.Shareholder Update and...
    Drone Stock Review. Draganfly

    Draganfly (DPRO) Shareholder Call Today, 4PM EST.

    Drones Editor / Curator -
    https://youtu.be/SwKfEfKi8rU Shareholder update call today August 12, 2021 at 2PM MST / 4PM EST.
    12Page 2 of 2

    Latest article

    We’re in Tampa for the Kentucky Derby.

    2024 Watch List Editor / Curator -
    GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

    Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

    Institutional Analyst Newsletter Editor / Curator -
    DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

    Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

    2024 Watch List Editor / Curator -
    Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.